1-5 of 5
Michael Lill, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy Of a Pharmacokinetics-Directed IV Busulfan (Bu), Plus Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen With Autologous Hematopoietic Stem Cell Transplantation For Lymphoma: Final Report Of a Multi-Center Phase 2 Study In North America

Christopher R. Flowers, MD, Michael Lill, M.D., Luciano J Costa, MD, PhD, Tsiporah B. Shore, William Vaughan, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, M.D., Mitchell E. Horwitz, MD, Joseph W. Fay, MD, Shin Mineishi, MD, Damiano Rondelli, MD, James Mason, MD, Vijay Reddy, MD, PhD, Ira Braunschweig, MD, Weiyun Ai, MD, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Cathy Zhao, PhD, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, Edmund K. Waller, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 768.
https://doi.org/10.1182/blood.V122.21.768.768
Published: 2013
Journal Articles

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

William I. Bensinger, MD, Pamela S Becker, MD, PhD, Ted A. Gooley, PhD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Robert Vescio, MD, Ajay K. Gopal, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD, Michael Lill, M.D., Leona Holmberg, MD, PhD, Jainulabdeen J Ifthikharuddin, MD, Gordon L. Phillips, II, MD
Journal: Blood
Blood (2012) 120 (21): 2009.
https://doi.org/10.1182/blood.V120.21.2009.2009
Published: 2012
Journal Articles

Safety of PK-Guided IV Bu Cy VP-16 Preparative Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Lymphoma: Findings From a Multi-Center Phase II Study in North America

Luciano J Costa, MD, PhD, Michael Lill, M.D., Rosa F. Yeh, PharmD, Robert K Stuart, MD, Stephen Lim, MD, Edmund K. Waller, MD, PhD, Tsiporah B. Shore, MD, Michael Craig, MD, Cesar O. Freytes, MD, Thomas C. Shea, MD, Tulio E. Rodriguez, MD, Ian W. Flinn, MD, PhD, Terrance Comeau, MD, FRCPC, Michael A. Pulsipher, MD, Isabelle Bence-Bruckler, MD, FRCPC, Pierre Laneuville, MD, Philip Bierman, MD, Andy I. Chen, MD, PhD, Louie H. Yu, BS, Shiva Patil, PhD, Yiping Sun, PhD, Elizabeth Armstrong, MS, Angela Smith, MS, PA, Agnes Elekes, MD, Kazunobu Kato, MD, PhD, William Vaughan, MD
Journal: Blood
Blood (2012) 120 (21): 813.
https://doi.org/10.1182/blood.V120.21.813.813
Published: 2012
Journal Articles

Stem Cell Transplantation for Relapsed and Refractory Burkitt Lymphoma.

Steven Kwon, M.D., Amir Steinberg, MD, Catherine Bresee, M.S., Mercedes Franco, Angela M. Lopez, MD, Stephen Lim, MD, Michael Lill, M.D.
Journal: Blood
Blood (2010) 116 (21): 4589.
https://doi.org/10.1182/blood.V116.21.4589.4589
Published: 2010
Journal Articles

Resource Utilization and Perceptions of Major Molecular Response In Chronic Myeloid Leukemia (CML): Results of a Delphi Panel Study.

Alfonso Quintas-Cardama, MD, Michael Flamm, MD, PhD, Michael Lill, M.D., Michael J Thirman, Farhad Ravandi, MD, Luke Paul Akard, MD, Moshe Talpaz, MD
Journal: Blood
Blood (2010) 116 (21): 4479.
https://doi.org/10.1182/blood.V116.21.4479.4479
Published: 2010